Eir Pharma ApS: Financial statements 2024
CVR: 44476533
Source: annual report 2024, Danish Business Authority
05/12/2023 – 31/12/2024
Eir Pharma ApS (CVR 44476533) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -25,687 and a net result of DKK -26,791. Equity in the 2024 report amounted to DKK 13,209. The solvency ratio was 32.8%.
- Gross Profit
- DKK -25,687
- Profit/Loss
- DKK -26,791
- Equity
- DKK 13,209
- Total Assets
- DKK 40,250
- Employees
- 0
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Eir Pharma ApS
Eir Pharma ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2023. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Sana Pharma Danmark ApS. The management consists of Heidi Tveit. The company is owned by Sana Pharma Medical ApS. In 2025, the company reported a gross profit of DKK -333,770 and a net result of DKK -361,247 compared with DKK -26,791 the year before. Equity in the 2025 report amounted to DKK -348,038.